A Step Towards Innovation: The Progressive Escalation of Genetic Cancer Biomarker Market in North America | UnivDatos
North America has shown its potential in several arenas, and genetic cancer biomarker is one of them. Genetic cancer biomarkers are essentially genetic alterations or mutations that can be identified in a person's DNA and are associated with the development or progression of cancer. They can include mutations, changes in gene expression, or variations in DNA sequence that are linked to an individual's predisposition to cancer, its diagnosis, prognosis, or response to certain treatments. According to the UnivDatos Market Insights analysis, the surge in the incidences of alcohol and tobacco prevalence and the associated surge in the demand for genetic cancer biomarkers will drive the global market of genetic cancer biomarkers and as per their “ Genetic Cancer Biomarker Market ” report, the global market was valued at USD 3.85 billion in 2022, growing at a CAGR of 18.4% during the forecast period from 2023 - 2030 to reach USD 12.1 billion by 2030. These biomarkers are essentia...